Niacin stimulates adiponectin secretion through the GPR109A receptor.

@article{Plaisance2009NiacinSA,
  title={Niacin stimulates adiponectin secretion through the GPR109A receptor.},
  author={Eric P. Plaisance and Martina Luk{\'a}{\vs}ov{\'a} and Stefan Offermanns and Youyan Zhang and Guoqing Cao and Robert L. Judd},
  journal={American journal of physiology. Endocrinology and metabolism},
  year={2009},
  volume={296 3},
  pages={
          E549-58
        }
}
Niacin (nicotinic acid) has recently been shown to increase serum adiponectin concentrations in men with the metabolic syndrome. However, little is known about the mechanism(s) by which niacin regulates the intracellular trafficking and secretion of adiponectin. Since niacin appears to exert its effects on lipolysis through receptor (GPR109A)-dependent and -independent pathways, the purpose of this investigation was to examine the role of the recently identified GPR109A receptor in adiponectin… 
Nicotinic Acid Increases Adiponectin Secretion from Differentiated Bovine Preadipocytes through G-Protein Coupled Receptor Signaling
TLDR
The NA-stimulated secretion of adiponectin and the mRNA expression of chemerin in the bovine adipocytes were suggestive of GPR signaling-dependent improved insulin sensitivity and/or adipocyte metabolism in dairy cows.
Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109A Dependent Mechanisms
TLDR
Nicotinic acid displays a range of effects that are lipoprotein-independent and potentially antiatherogenic, which suggest a rationale for treatment with NA that is not dependent on levels of plasma cholesterol and possible applications beyond the treatment of dyslipidemia.
Adipocyte P2Y14 receptors play a key role in regulating whole-body glucose and lipid homeostasis
TLDR
It is demonstrated that adipose P2y14Rs were critical regulators of whole-body glucose and lipid homeostasis, suggesting that P2Y14R antagonists might be beneficial for the therapy of obesity and T2D.
Future of GPR109A agonists in the treatment of dyslipidaemia
TLDR
This review presents what is known to date about G PR109A biology and function and the future of GPR109A as a pharmacological target and suggests it could play a crucial part in its role as a lipid‐modifying drug.
Screening for adiponectin secretion regulators.
Regulation of adiponectin expression by trans-cinnamic acid and niacin in murine and bovine adipocytes in vitro
Adipose tissue secretes multiple metabolically important proteins known as adipokines. One of the most abundant adipokines in circulation is adiponectin (AdipoQ), which is known as an important
Trans-Cinnamic Acid Increases Adiponectin and the Phosphorylation of AMP-Activated Protein Kinase through G-Protein-Coupled Receptor Signaling in 3T3-L1 Adipocytes
TLDR
The inhibitory effect of PTX suggests GPR is involved in tCA stimulated signaling, which hypothesize whether AMPK activation and adiponectin secretion by tCA is transmitted by GPR signaling.
Niacin in Cardiovascular Disease: Recent Preclinical and Clinical Developments
TLDR
The recent reports of anti-inflammatory effects of niacin in adipocytes and through bone marrow derived cells and vascular endothelium are discussed, and mechanisms of action on lipoproteins, which remain complex and incompletely understood are reviewed.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
TLDR
It is shown that the orphan G-protein-coupled receptor, 'protein upregulated in macrophages by interferon-γ' (mouse PUMA-G, human HM74), is highly expressed in adipose tissue and is a nicotinic acid receptor.
Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A.
Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism.
Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids.
TLDR
In a mouse in vivo model, the activation of GPR43 by acetate results in the reduction in plasma free fatty acid levels without inducing the flushing side effect that has been observed by theactivation of nicotinic acid receptor, GPR109A.
Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors*
TLDR
A number of GPR109A pyrazole agonists are identified that are capable of fully inhibiting lipolysis in vitro and in vivo and not only fail to elicit a flushing response but can antagonize the ability of nicotinic acid to elicite a flush response in vivo.
(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G*
TLDR
It is shown that the fatty acid-derived ketone body (d)-β-hydroxybutyrate ((d-β-OHB) specifically activates PUMA-G/HM74a at concentrations observed in serum during fasting, thereby preventing ketoacidosis and promoting efficient use of fat stores.
Molecular identification of nicotinic acid receptor.
...
1
2
3
4
...